A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies.
Palmer S, Borget I, Friede T, Husereau D, Karnon J, Kearns B, Medin E, Peterse EFP, Klijn SL, Verburg-Baltussen EJM, Fenwick E, Borrill J.
Palmer S, et al. Among authors: borrill j.
Value Health. 2023 Feb;26(2):185-192. doi: 10.1016/j.jval.2022.07.009. Epub 2022 Aug 13.
Value Health. 2023.
PMID: 35970706
Free article.